 | | Darunavir (Prezista) |  | | Published
August 09, 2006; Updated
October 19, 2011 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-03-10 | | | Selected References | | 4. | Darunavir [package insert]. East Bridgewater, NJ: Tibotec Therapeutics: 2010; update forthcoming. | |
| 10. | De Meyer S, A Hill, De Baere I, et al. Effect of Baseline Susceptibility and On-treatment Mutations on TMC114 and Control PI Efficacy: Preliminary Analysis of Data from PI-experienced Patients from POWER 1 and POWER 2. In: Program and abstracts of the 13th Conference on Retroviruses and Opportunistic Infections; February 5-9, 2006; Denver. Abstract 157. | |
|
|
|
